Oruka Therapeutics (ORKA) Institutional Ownership $9.22 +0.61 (+7.03%) Closing price 04/17/2025 03:59 PM EasternExtended Trading$9.20 -0.01 (-0.11%) As of 04/17/2025 04:01 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Oruka Therapeutics (NASDAQ:ORKA)CurrentInstitutional OwnershipPercentage56.44%Number ofInstitutional Buyers(last 12 months)37TotalInstitutional Inflows(last 12 months)$396.61MNumber ofInstitutional Sellers(last 12 months)3TotalInstitutional Outflows(last 12 months)$14.30M Get ORKA Insider Trade Alerts Want to know when executives and insiders are buying or selling Oruka Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data ORKA Institutional Buying and Selling by Quarter Oruka Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails3/24/2025Wellington Management Group LLP95,089$1.84M0.0%+15.8%0.254% 2/27/2025Jefferies Financial Group Inc.350,029$6.79M0.0%N/A1.000% 2/19/2025Toronto Dominion Bank58,332$1.13M0.0%N/A0.167% 2/18/2025Frazier Life Sciences Management L.P.583,327$11.31M0.5%+22.2%1.667% 2/17/2025VR Adviser LLC3,285,620$63.71M4.4%+6.5%9.387% 2/17/2025Squarepoint Ops LLC12,175$236K0.0%N/A0.035% 2/17/2025Toronto Dominion Bank58,332$1.13M0.0%N/A0.167% 2/17/2025RTW Investments LP1,945,649$37.73M0.6%+5.1%5.559% 2/17/2025Point72 Asset Management L.P.360,732$7.00M0.0%-25.2%1.031% 2/17/2025Polar Capital Holdings Plc550,000$10.66M0.1%N/A1.571% Get the Latest News and Ratings for ORKA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Oruka Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 2/17/2025Paradigm Biocapital Advisors LP819,660$15.89M0.6%+13.9%2.342% 2/17/2025OMERS ADMINISTRATION Corp19,800$384K0.0%N/A0.057% 2/17/2025Millennium Management LLC30,305$588K0.0%N/A0.087% 2/17/2025Janus Henderson Group PLC849,410$16.42M0.0%+259.7%2.427% 2/17/2025Jefferies Financial Group Inc.350,029$6.79M0.0%N/A1.000% 2/17/2025Fairmount Funds Management LLC3,371,922$65.38M6.5%+5.0%9.634% 2/17/2025Deep Track Capital LP750,000$14.54M0.5%-39.3%2.143% 2/17/2025Braidwell LP1,147,676$22.25M0.7%+122.5%3.279% 2/17/2025Blackstone Inc.240,174$4.66M0.0%N/A0.686% 2/17/2025Allostery Investments LP20,000$388K0.4%N/A0.057% 2/17/2025683 Capital Management LLC33,875$657K0.0%N/A0.097% 2/14/2025Jane Street Group LLC17,706$343K0.0%N/A0.051% 2/14/2025Northern Trust Corp64,044$1.24M0.0%N/A0.183% 2/14/2025Adage Capital Partners GP L.L.C.69,200$1.34M0.0%-65.4%0.198% 2/14/2025Price T Rowe Associates Inc. MD1,326,893$25.73M0.0%+374.5%3.791% 2/14/2025B Group Inc.20,000$388K0.2%N/A0.057% 2/13/2025SR One Capital Management LP430,330$8.34M2.0%+14.7%1.230% 2/13/2025Affinity Asset Advisors LLC368,698$7.15M1.0%+5.4%1.053% 2/13/2025Barclays PLC74,583$1.45M0.0%N/A0.213% 2/13/2025Kennedy Capital Management LLC60,494$1.17M0.0%N/A0.173% 2/13/2025FMR LLC5,512,300$106.88M0.0%+17.7%15.749% 2/12/2025Geode Capital Management LLC342,418$6.64M0.0%+2,348.6%0.978% 2/12/2025Wellington Management Group LLP95,089$1.84M0.0%+15.8%0.272% 2/12/2025JPMorgan Chase & Co.2,800$54K0.0%N/A0.008% 2/11/2025Vanguard Group Inc.1,610,651$31.23M0.0%+4,161.2%4.602% 2/6/2025Charles Schwab Investment Management Inc.15,608$303K0.0%N/A0.045% 1/31/2025AlphaCentric Advisors LLC6,140$119K0.1%N/A0.018% 1/24/2025China Universal Asset Management Co. Ltd.7,421$144K0.0%N/A0.021% 11/27/2024Franklin Resources Inc.720,547$17.66M0.0%N/A2.059% 11/16/2024Geode Capital Management LLC13,984$343K0.0%N/A1.156% $2 Trillion Disappears Because of Fed's Secretive New Move (Ad)$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being carried out by the Fed that has nothing to do with lowering or raising interest rates... but could soon have an enormous impact on your wealth.Click here to see his new research now.11/15/2024Frazier Life Sciences Management L.P.477,327$11.70M0.5%N/A39.449% 11/15/2024Wellington Management Group LLP82,137$2.01M0.0%N/A6.788% 11/15/2024RTW Investments LP1,850,648$45.36M0.7%N/A152.946% 11/15/2024Redmile Group LLC411,728$10.09M0.6%N/A34.027% 11/15/2024Point72 Asset Management L.P.482,330$11.82M0.0%N/A39.862% 11/15/2024Janus Henderson Group PLC236,116$5.84M0.0%N/A19.514% 11/14/2024Braidwell LP515,726$12.64M0.4%N/A42.693% 11/13/2024Great Point Partners LLC514,659$12.61M3.7%N/A42.534% 11/13/2024FMR LLC4,682,300$114.76M0.0%N/A386.967% 11/13/2024The Manufacturers Life Insurance Company42,298$1.04M0.0%N/A3.496% (Data available from 1/1/2016 forward) ORKA Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of ORKA shares? During the previous two years, 39 institutional investors and hedge funds held shares of Oruka Therapeutics. The most heavily invested institutionals were FMR LLC ($106.88M), Fairmount Funds Management LLC ($65.38M), VR Adviser LLC ($63.71M), RTW Investments LP ($37.73M), Vanguard Group Inc. ($31.23M), Price T Rowe Associates Inc. MD ($25.73M), and Braidwell LP ($22.25M).Learn more on ORKA's institutional investors. What percentage of Oruka Therapeutics stock is owned by institutional investors? 56.44% of Oruka Therapeutics stock is owned by institutional investors. Learn more on ORKA's institutional investor holdings. Which institutional investors have been buying Oruka Therapeutics stock? Of the 37 institutional investors that purchased Oruka Therapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: FMR LLC ($5.51M), RTW Investments LP ($1.95M), Vanguard Group Inc. ($1.57M), Braidwell LP ($1.15M), Price T Rowe Associates Inc. MD ($1.05M), Janus Henderson Group PLC ($849.41K), and Franklin Resources Inc. ($720.55K). How much institutional buying is happening at Oruka Therapeutics? Institutional investors have bought a total of 17,806,190 shares in the last 24 months. This purchase volume represents approximately $396.61M in transactions. Which Oruka Therapeutics major shareholders have been selling company stock? The following institutional investors have sold Oruka Therapeutics stock in the last 24 months: Deep Track Capital LP ($485.19K), Adage Capital Partners GP L.L.C. ($130.80K), and Point72 Asset Management L.P. ($121.60K). How much institutional selling is happening at Oruka Therapeutics? Institutional investors have sold a total of 737,585 shares in the last 24 months. This volume of shares sold represents approximately $14.30M in transactions. Related Companies ARDX Institutional Ownership EVO Institutional Ownership AUPH Institutional Ownership OCUL Institutional Ownership IOVA Institutional Ownership SNDX Institutional Ownership WVE Institutional Ownership COLL Institutional Ownership ELVN Institutional Ownership DYN Institutional Ownership This page (NASDAQ:ORKA) was last updated on 4/18/2025 by MarketBeat.com Staff From Our PartnersElon Reveals Why There Soon Won’t Be Any Money For Social SecurityElon Musk's Near-Death Experience Sparks Dire Warning for Americans After cheating death twice—once in a te...Colonial Metals | SponsoredClaim Your FREE Protection GuideIn the final days of his first term, Trump quietly left open an "off the books" wealth-protection loophole hid...American Alternative | SponsoredThe first casualty of the 2025 trade warThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | SponsoredIs it CRAZY to still want reliable profits, despite this market?Larry Benedict, the acclaimed "Market Wizard," is calling an emergency briefing now... The same Larry who –...Brownstone Research | SponsoredHow War with China Could Start in 128 DaysThe clock is ticking. Those who aren't prepared could lose everything. I've identified 43 investments we...Behind the Markets | SponsoredMy prediction is coming trueWe've developed a surprisingly effective way to see which stocks could double during massive shake-ups, by usi...InvestorPlace | SponsoredTrump Orders 'National Digital Asset Stockpile'‘Digital Asset Reserve’ for THIS Coin??? Get all the details before this story gains even more tractionCrypto 101 Media | SponsoredCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Oruka Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Oruka Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.